Δ9Tetrahydrocannabinol impairs reversal learning but not extra-dimensional shifts in rhesus macaques

Neuroscience

Volumn 235, Issue , 2013, Pages 51-58

  Wright, M J ^a   Vandewater, S A ^a   Parsons, L H ^a   Taffe, M A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cannabis; Extradimensional shift; Macaca mulatta; Marijuana; Reversal learning

Indexed keywords

DRONABINOL;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; DISCRIMINATION LEARNING; DISEASE ASSOCIATION; LEARNING DISORDER; MALE; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; MOTOR PERFORMANCE; NONHUMAN; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; SELECTIVE ATTENTION; SHORT TERM MEMORY; SPATIAL MEMORY; WORKING MEMORY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COGNITION; DATA INTERPRETATION, STATISTICAL; HALLUCINOGENS; INJECTIONS, INTRAVENOUS; LEARNING DISORDERS; MACACA MULATTA; MALE; MEMORY, SHORT-TERM; MOTOR SKILLS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOMOTOR PERFORMANCE; REVERSAL LEARNING; SPACE PERCEPTION; TETRAHYDROCANNABINOL;

EID: 84873729955     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.01.018     Document Type: Article

References (69)

1. Aigner T.G. Delta-9-tetrahydrocannabinol impairs visual recognition memory but not discrimination learning in rhesus monkeys. Psychopharmacology 1988, 95:507-511.
2. Ali S.F., Newport G.D., Scallet A.C., Gee K.W., Paule M.G., Brown R.M., Slikker W. Effects of chronic delta-9-tetrahydrocannabinol (THC) administration on neurotransmitter concentrations and receptor binding in the rat brain. Neurotoxicology 1989, 10:491-500.
3. Azorlosa J.L., Heishman S.J., Stitzer M.L., Mahaffey J.M. Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs. J Pharmacol Exp Ther 1992, 261:114-122.
4. Azorlosa J.L., Greenwald M.K., Stitzer M.L. Marijuana smoking: effects of varying puff volume and breathhold duration. J Pharmacol Exp Ther 1995, 272:560-569.
5. Bailey J.R., Cunny H.C., Paule M.G., Slikker W. Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. Toxicol Appl Pharmacol 1987, 90:315-321.
6. Biswas B., Deb G., Ghosh J.J. Changes in rat adrenal medulla following delta9-tetrahydrocannabinol treatment. A histochemical study. Acta Endocrinol 1975, 80:329-338.
7. Brady K.T., Balster R.L. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys. Psychopharmacology 1980, 72:21-26.
8. Branch M.N., Dearing M.E., Lee D.M. Acute and chronic effects of delta 9-tetrahydrocannabinol on complex behavior of squirrel monkeys. Psychopharmacology 1980, 71:247-256.
9. Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., Vogt L.J., Sim-Selley L.J. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem 1999, 73:2447-2459.
10. Buffalo E.A., Bellgowan P.S., Martin A. Distinct roles for medial temporal lobe structures in memory for objects and their locations. Learning & memory 2006, 13:638-643. (Cold Spring Harbor, NY).
11. Clark JD, Baldwin RL, Bayne KA, Brown MJ, Gebhart GF, Gonder JC, Gwathmey JK, Keeling ME, Kohn DF, Robb JW, Smith OA, Steggarda J-AD, Vandenbergh JG, White WJ, Williams-Blangero S, VandeBerg JL (1996) Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animal Resources, National Research Council, Washington DC, pp 125.
12. Collins P., Roberts A.C., Dias R., Everitt B.J., Robbins T.W. Perseveration and strategy in a novel spatial self-ordered sequencing task for nonhuman primates: effects of excitotoxic lesions and dopamine depletions of the prefrontal cortex. J Cogn Neurosci 1998, 10:332-354.
13. Cone E.J., Huestis M.A. Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage. Ther Drug Monit 1993, 15:527-532.
14. Corchero J., Oliva J.M., Garcia-Lecumberri C., Martin S., Ambrosio E., Manzanares J. Repeated administration with Delta9-tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain. J Psychopharmacol 2004, 18:54-58.
15. Crean R.D., Crane N.A., Mason B.J. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 2011, 5:1-8.
16. Crean R.D., Tapert S.F., Minassian A., Macdonald K., Crane N.A., Mason B.J. Effects of chronic, heavy cannabis use on executive functions. J Addict Med 2011, 5:9-15.
17. Crean R.D., Vandewater S.A., Katner S.N., Huitron-Resendiz S., Taffe M.A. Chronic alcohol consumption impairs visuo-spatial associative memory in periadolescent rhesus monkeys. Drug Alcohol Depend 2011, 114:31-40.
18. Dias R., Robbins T.W., Roberts A.C. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 1996, 380:69-72.
19. Dias R., Robbins T.W., Roberts A.C. Primate analogue of the Wisconsin card sorting test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav Neurosci 1996, 110:872-886.
20. Dias R., Robbins T.W., Roberts A.C. Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin card sort test: restriction to novel situations and independence from " on-line" processing. J Neurosci 1997, 17:9285-9297.
21. Egerton A., Brett R.R., Pratt J.A. Acute delta9-tetrahydrocannabinol-induced deficits in reversal learning: neural correlates of affective inflexibility. Neuropsychopharmacology 2005, 30:1895-1905.
22. Eggan S.M., Lewis D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex 2007, 17:175-191.
23. Ferraro D.P., Grilly D.M. Effects of chronic exposure to delta9-tetrahydrocannabinol on delayed matching-to-sample in chimpanzees. Psychopharmacologia 1974, 37:127-138.
24. Galbicka G., Lee D.M., Branch M.N. Schedule-dependent tolerance to behavioral effects of delta 9-tetrahydrocannabinol when reinforcement frequencies are matched. Pharmacol Biochem Behav 1980, 12:85-91.
25. Gluck J.P., Ferraro D.P., Marriott R.G. Retardation of discrimination reversal by delta9-tetrahydrocannabinol in monkeys. Pharmacol Biochem Behav 1973, 1:605-608.
26. Gorelick D.A., Heishman S.J., Preston K.L., Nelson R.A., Moolchan E.T., Huestis M.A. The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. Am Heart J 2006, 151:754e1-754e5.
27. Hampson R.E., Espana R.A., Rogers G.A., Porrino L.J., Deadwyler S.A. Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717. Psychopharmacology (Berl) 2009, 202:355-369.
28. Healy J. Voters Ease Marijuana Laws in 2 States, but Legal Questions Remain New York Times 2012, The New York Times Company, New York, New York.
29. Hienz R.D., Turkkan J.S., Spear D.J., Sannerud C.A., Kaminski B.J., Allen R.P. General activity in baboons measured with a computerized, lightweight piezoelectric motion sensor: effects of drugs. Pharmacol Biochem Behav 1992, 42:497-507.
30. Huang W., Moody D.E., Andrenyak D.M., Smith E.K., Foltz R.L., Huestis M.A., Newton J.F. Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry. J Anal Toxicol 2001, 25:531-537.
31. Ichihara-Takeda S., Funahashi S. Reward-period activity in primate dorsolateral prefrontal and orbitofrontal neurons is affected by reward schedules. J Cogn Neurosci 2006, 18:212-226.
32. Ichihara-Takeda S., Funahashi S. Activity of primate orbitofrontal and dorsolateral prefrontal neurons: task-related activity during an oculomotor delayed-response task. Exp Brain Res 2007, 181:409-425.
33. Ichihara-Takeda S., Funahashi S. Activity of primate orbitofrontal and dorsolateral prefrontal neurons: effect of reward schedule on task-related activity. J Cogn Neurosci 2008, 20:563-579.
34. Inoue M., Mikami A., Ando I., Tsukada H. Functional brain mapping of the macaque related to spatial working memory as revealed by PET. Cereb Cortex 2004, 14:106-119.
35. Johnston L.D., O'Malley P.M., Bachman J.G., Scheulenberg J.E. Monitoring the Future national survey results on drug use 1975-2010 2011, vol. I, Secondary School Students. University of Michigan, Ann Arbor, p. 734.
36. Johnston L.D., O'Malley P.M., Bachman J.G., Scheulenberg J.E. Monitoring the Future national survey results on drug use, 1975-2010 2011, vol. II, College students and adults ages 19-45. University of Michigan, Ann Arbor, p. 312.
37. Landfield P.W., Cadwallader L.B., Vinsant S. Quantitative changes in hippocampal structure following long-term exposure to delta 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems. Brain Res 1988, 443:47-62.
38. Malkova L., Mishkin M. One-trial memory for object-place associations after separate lesions of hippocampus and posterior parahippocampal region in the monkey. J Neurosci 2003, 23:1956-1965.
39. Mao Z.M., Arnsten A.F., Li B.M. Local infusion of an alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys. Biol Psychiatry 1999, 46:1259-1265.
40. Nakamura-Palacios E.M., Winsauer P.J., Moerschbaecher J.M. Effects of the cannabinoid ligand SR 141716A alone or in combination with delta9-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys. Behav Pharmacol 2000, 11:377-386.
41. Oscar-Berman M. The effects of dorsolateral-frontal and ventrolateral-orbitofrontal lesions on spatial discrimination learning and delayed response in two modalities. Neuropsychologia 1975, 13:237-246.
42. Pieper W.A. Great apes and rhesus monkeys as subjects for psychopharmacological studies of stimulants and depressants. Fed Proc 1976, 35:2254-2257.
43. Romero J., Berrendero F., Manzanares J., Perez A., Corchero J., Fuentes J.A., Fernandez-Ruiz J.J., Ramos J.A. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol. Synapse 1998, 30:298-308.
44. Rubino T., Vigano D., Massi P., Spinello M., Zagato E., Giagnoni G., Parolaro D. Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions. Neuropharmacology 2000, 39:1331-1336.
45. Rudebeck P.H., Behrens T.E., Kennerley S.W., Baxter M.G., Buckley M.J., Walton M.E., Rushworth M.F. Frontal cortex subregions play distinct roles in choices between actions and stimuli. J Neurosci 2008, 28:13775-13785.
46. Rupniak N.M., Samson N.A., Steventon M.J., Iversen S.D. Induction of cognitive impairment by scopolamine and noncholinergic agents in rhesus monkeys. Life Sci 1991, 48:893-899.
47. Sagredo O., Ramos J.A., Fernandez-Ruiz J., Rodriguez M.L., de Miguel R. Chronic Delta(9)-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex. Naunyn Schmiedebergs Arch Pharmacol 2006, 372:313-317.
48. Schulze G.E., McMillan D.E., Bailey J.R., Scallet A., Ali S.F., Slikker W., Paule M.G. Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests. J Pharmacol Exp Ther 1988, 245:178-186.
49. Schulze G.E., McMillan D.E., Bailey J.R., Scallet A.C., Ali S.F., Slikker W., Paule M.G. Acute effects of marijuana smoke on complex operant behavior in rhesus monkeys. Life Sci 1989, 45:465-475.
50. Slikker W., Paule M.G., Ali S.F., Scallet A.C., Bailey J.R. Chronic marijuana smoke exposure in the rhesus monkey. I. Plasma cannabinoid and blood carboxyhemoglobin concentrations and clinical chemistry parameters. Fundam Appl Toxicol 1991, 17:321-334.
51. Sokolic L., Long L.E., Hunt G.E., Arnold J.C., McGregor I.S. Disruptive effects of the prototypical cannabinoid Delta-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats. Behav Pharmacol 2011, 22:191-202.
52. Stark P., Dews P.B. Cannabinoids. I. Behavioral effects. J Pharmacol Exp Ther 1980, 214:124-130.
53. Taffe M.A. Effects of parametric feeding manipulations on behavioral performance in macaques. Physiol Behav 2004, 81:59-70.
54. Taffe M.A. Erratum effects of parametric feeding manipulations on behavioral performance in macaques. Physiol Behav 2004, 82-589.
55. Taffe M.A. Delta9-tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys. Neuroscience 2012, 201:125-133.
56. Taffe M.A. Delta(9) tetrahydrocannabinol impairs visuo-spatial associative learning and spatial working memory in rhesus macaques. J Psychopharmacol 2012, 26:1299-1306.
57. Taffe M.A., Weed M.R., Gutierrez T., Davis S.A., Gold L.H. Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys. Psychopharmacology 2002, 160:253-262.
58. Taffe M.A., Weed M.R., Gutierrez T., Davis S.A., Gold L.H. Modeling a task that is sensitive to dementia of the Alzheimer's type: individual differences in acquisition of a visuo-spatial paired-associate learning task in rhesus monkeys. Behav Brain Res 2004, 149:123-133.
59. Tremblay L., Schultz W. Relative reward preference in primate orbitofrontal cortex. Nature 1999, 398:704-708.
60. Varvel S.A., Lichtman A.H. Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 2002, 301:915-924.
61. Verdejo-Garcia A., Del Mar Sanchez-Fernandez M., Alonso-Maroto L.M., Fernandez-Calderon F., Perales J.C., Lozano O., Perez-Garcia M. Impulsivity and executive functions in polysubstance-using rave attenders. Psychopharmacology (Berl) 2010, 210:377-392.
62. Verrico C.D., Liu S., Bitler E.J., Gu H., Sampson A.R., Bradberry C.W., Lewis D.A. Delay- and dose-dependent effects of Delta(9)-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys. Neuropsychopharmacology 2012, 37:1357-1366.
63. Weed M.R., Taffe M.A., Polis I., Roberts A.C., Robbins T.W., Koob G.F., Bloom F.E., Gold L.H. Performance norms for a rhesus monkey neuropsychological testing battery: acquisition and long-term performance. Brain Res Cogn Brain Res 1999, 8:185-201.
64. Winsauer P.J., Molina P.E., Amedee A.M., Filipeanu C.M., McGoey R.R., Troxclair D.A., Walker E.M., Birke L.L., Stouwe C.V., Howard J.M., Leonard S.T., Moerschbaecher J.M., Lewis P.B. Tolerance to chronic delta-9-tetrahydrocannabinol (Delta-THC) in rhesus macaques infected with simian immunodeficiency virus. Exp Clin Psychopharmacol 2011, 19:154-172.
65. Wright M.J., Taffe M.A., Disorders C.N.A. Effects of Ethanol on Reversal Learning and Extra-Dimensional Attentional Shift in Rhesus Macaques. Alcoholism-Clinical and Experimental Research 2010, 34. 30a.
66. Wright MJ Jr., Glavis-Bloom C, Taffe MA (2013) Acute ethanol reduces reversal cost in discrimination learning by reducing perseverance in adolescent rhesus macaques. Alcohol Clin Exp Res. [Epub ahead of print]. http://dx.doi.org/10.1111/acer.12050.
67. Wright M.J., Vandewater S.A., Angrish D., Dickerson T.J., Taffe M.A. Mephedrone (4-methylmethcathinone) and d-methamphetamine improve visuospatial associative memory, but not spatial working memory, in rhesus macaques. Brit J Pharmacol 2012, 167:1342-1352.
68. Wu Y.H., Lin K.L., Chen S.C., Chang Y.Z. Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair. J Chromatogr B 2008, 870:192-202.
69. Zola-Morgan S., Squire L.R. Medial temporal lesions in monkeys impair memory on a variety of tasks sensitive to human amnesia. Behav Neurosci 1985, 99:22-34.